Bell Bank Pfizer Inc Transaction History

Bell Bank

$837 Million
Q3 2024

A detailed history of Bell Bank transactions in Pfizer Inc stock. As of the latest transaction made, Bell Bank holds 279,031 shares of PFE stock, worth $7.42 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

279,031

Previous 327,105 14.7%

Holding current value

$7.42 Million

Previous $9.15 Million 11.77%

% of portfolio

0.97%

Previous 0.78%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $1.33 Million - $1.51 Million	-48,074 Reduced 14.7%	279,031 $8.08 Million
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $2.1 Million - $2.46 Million	83,136 Added 34.08%	327,105 $9.15 Million
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $723,211 - $830,477	27,934 Added 12.93%	243,969 $6.77 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $244,576 - $317,678	9,360 Added 4.53%	216,035 $6.22 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $3.41 Million - $3.98 Million	106,124 Added 105.54%	206,675 $6.86 Million
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $51,940 - $60,094	1,438 Added 1.45%	100,551 $3.69 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $2.76 Million - $3.6 Million	70,163 Added 242.36%	99,113 $4.04 Million
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $85,712 - $111,888	2,053 Added 7.63%	28,950 $1.48 Million
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $7,614 - $9,295	-174 Reduced 0.64%	26,897 $1.18 Million
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $169,601 - $201,094	-3,645 Reduced 11.87%	27,071 $1.42 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $5.31 Million - $6.58 Million	-116,058 Reduced 79.07%	30,716 $1.59 Million
Q4 2021 Feb 01, 2022	BUY	$41.32 - $61.25 $563,935 - $835,940	13,648 Added 10.25%	146,774 $8.67 Million
Q3 2021 Oct 22, 2021	BUY	$39.25 - $50.42 $68,255 - $87,680	1,739 Added 1.32%	133,126 $5.73 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $338,308 - $383,246	9,421 Added 7.72%	131,387 $5.15 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $372,743 - $420,380	11,130 Added 10.04%	121,966 $4.42 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $212,233 - $269,872	6,341 Added 6.07%	110,836 $4.08 Million
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $136,429 - $160,063	-4,297 Reduced 3.95%	104,495 $3.84 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $147,588 - $179,046	-4,900 Reduced 4.31%	108,792 $3.56 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $495,297 - $707,672	18,324 Added 19.21%	113,692 $3.71 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $2.79 Million - $3.17 Million	84,777 Added 800.46%	95,368 $3.74 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $8,154 - $10,574	-251 Reduced 2.32%	10,591 $381,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $4,178 - $4,691	-113 Reduced 1.03%	10,842 $470,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $2.92 Million - $3.21 Million	-77,977 Reduced 87.68%	10,955 $465,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $130,836 - $149,167	-3,401 Reduced 3.68%	88,932 $3.88 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $200,270 - $242,916	-5,810 Reduced 5.92%	92,333 $4.07 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $143,298 - $152,770	-4,345 Reduced 4.24%	98,143 $3.56 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $351 - $407	11 Added 0.01%	102,488 $3.64 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $660,443 - $700,753	-19,857 Reduced 16.23%	102,477 $3.71 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $31,868 - $35,106	-1,028 Reduced 0.83%	122,334 $4.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	123,362	123,362 $4.14 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bell Bank with notifications on news.

Account